Interleukin-2 has no additional therapeutic efficacy in the retreatment of patients with chronic hepatitis C that had not responded to interferon-α plus ribavirin
2003 ◽
Vol 33
(7)
◽
pp. 628-629
◽
Keyword(s):
1995 ◽
Vol 40
(8)
◽
pp. 1837-1841
◽
Keyword(s):
2012 ◽
Vol 30
(5)
◽
pp. 1048-1052
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 38
(3)
◽
pp. 315-318
◽
Keyword(s):
2013 ◽
Vol 20
(1)
◽
pp. 35
◽
Keyword(s):
Keyword(s):